LH expands specialty testing, acquisitions and AI initiatives to drive growth, but macro pressures and currency headwinds ...

Earlier this week, Labcorp announced the nationwide availability of ColoSense, the first FDA-approved RNA-based at-home ...

ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

The nationwide rollout, which Labcorp disclosed Monday, comes weeks after the Centers for Medicare and Medicaid Services approved coverage for ColoSense, and the American Cancer Society named the test ...

With a market cap of $23.3 billion, Labcorp Holdings Inc. (LH) is a global life sciences and healthcare company. The North ...

North Carolina-based LabCorp Diagnostics, one of the largest clinical laboratories in the U.S., was forced to shut down its network on Sunday after officials detected suspicious activity, according to ...

Labcorp is a global life sciences company headquartered in Burlington, North Carolina. Labcorp provides at-home test kits as well as in-person testing at their laboratory facilities, which are located ...

Collaboration leverages Olaris' scientific leadership in transplant diagnostics and Labcorp's scientific expertise and national scale to advance post-transplant monitoring. FRAMINGHAM, Mass.

Labcorp currently trades at $265.08 per share and has shown little upside over the past six months, posting a middling return ...

Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2026 before the market opens on ...